|
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Clinical Investigation |
1 Department of Molecular Medicine and Surgery, Karolinska University Hospital, Stockholm, Sweden; 2 Department of Radiology, Karolinska University Hospital, Stockholm, Sweden; 3 Department of Vascular Surgery, Karolinska University Hospital, Stockholm, Sweden; 4 Department of Oncology and Pathology, Karolinska University Hospital, Stockholm, Sweden; and 5 Department of Hospital Physics, Karolinska University Hospital, Stockholm, Sweden
Correspondence: For correspondence or reprints contact: Johan Wassélius, Department of Molecular Medicine and Surgery, Karolinska University Hospital, Stockholm, Sweden 17176. E-mail: johan.wasselius{at}karolinska.se
Graft infection is a serious complication to vascular surgery. The aim of this study was to assess 18F-FDG uptake in vascular grafts in patients with or without symptoms of graft infection. Methods: In all 2,045 patients examined by PET/CT at our clinic, 16 patients with synthetic aortic grafts were identified and reevaluated for 18F-FDG accumulation. Clinical and biochemical data were obtained from patient records. Results: High 18F-FDG uptake was found in 10 of 12 grafts in the patients who underwent open surgery and in 1 of 4 grafts in patients who underwent endovascular aneurysm repair. On the basis of biochemical and clinical data, it was concluded that 1 of the 16 patients had a graft infection at the time of investigation. Conclusion: 18F-FDG uptake in vascular grafts was found in the vast majority of patients without graft infection. The risk of a false-positive diagnosis of graft infection by 18F-FDG PET/CT is evident.
Key Words: graft infection imaging nuclear medicine 18F-FDG PET/CT vascular surgery
COPYRIGHT © 2008 by the Society of Nuclear Medicine, Inc.
Related articles in JNM:
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |